1 April 2024 false No description of principal activity Taxfiler 2024.6 6857583 business:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 6857583 2024-03-31 6857583 2024-04-01 2025-03-31 6857583 business:AuditExemptWithAccountantsReport 2024-04-01 2025-03-31 6857583 business:FilletedAccounts 2024-04-01 2025-03-31 6857583 2025-03-31 6857583 business:Director1 2024-04-01 2025-03-31 6857583 business:Director2 2024-04-01 2025-03-31 6857583 business:RegisteredOffice 2024-04-01 2025-03-31 6857583 2024-03-31 6857583 core:WithinOneYear 2025-03-31 6857583 core:WithinOneYear 2024-03-31 6857583 core:AfterOneYear 2025-03-31 6857583 core:AfterOneYear 2024-03-31 6857583 core:ShareCapital core:PreviouslyStatedAmount 2025-03-31 6857583 core:ShareCapital core:PreviouslyStatedAmount 2024-03-31 6857583 core:RetainedEarningsAccumulatedLosses core:PreviouslyStatedAmount 2025-03-31 6857583 core:RetainedEarningsAccumulatedLosses core:PreviouslyStatedAmount 2024-03-31 6857583 core:PreviouslyStatedAmount 2025-03-31 6857583 core:PreviouslyStatedAmount 2024-03-31 6857583 business:SmallEntities 2024-04-01 2025-03-31 6857583 countries:EnglandWales 2024-04-01 2025-03-31 6857583 core:MotorVehicles 2024-04-01 2025-03-31 6857583 core:FurnitureFittings 2024-04-01 2025-03-31 6857583 core:Goodwill 2024-03-31 6857583 core:IntangibleAssetsOtherThanGoodwill 2024-03-31 6857583 core:Goodwill 2025-03-31 6857583 core:IntangibleAssetsOtherThanGoodwill 2025-03-31 6857583 core:LandBuildings 2024-03-31 6857583 core:MotorVehicles 2024-03-31 6857583 core:FurnitureFittings 2024-03-31 6857583 core:LandBuildings 2025-03-31 6857583 core:MotorVehicles 2025-03-31 6857583 core:FurnitureFittings 2025-03-31 6857583 core:LandBuildings 2024-04-01 2025-03-31 6857583 2023-04-01 2024-03-31 iso4217:GBP xbrli:pure
Company Registration No. 6857583 (England and Wales)
MMO Pharma Ltd Unaudited accounts for the year ended 31 March 2025
MMO Pharma Ltd Unaudited accounts Contents
Page
Company information
3
Statement of financial position
4
Notes to the accounts
5
- 2 -
MMO Pharma Ltd Company Information for the year ended 31 March 2025
Directors
Tahira Ahmed Saher Shoaib
Company Number
6857583 (England and Wales)
Registered Office
4 Rectory Lane Glinton Peterborough PE6 7LR
Accountants
Griffin and Sage Limited 172 Park Road Peterborough PE1 2UF
- 3 -
MMO Pharma Ltd Statement of financial position as at 31 March 2025
2025
2024
Notes
£
£
Fixed assets
Tangible assets
5
93,576
93,857
Current assets
Inventories
37,835
41,127
Debtors
6
378,777
345,734
Cash at bank and in hand
14,314
1,087
430,926
387,948
Creditors: amounts falling due within one year
7
(144,967)
(135,797)
Net current assets
285,959
252,151
Total assets less current liabilities
379,535
346,008
Creditors: amounts falling due after more than one year
8
(59,248)
(59,262)
Provisions for liabilities
Deferred tax
(190)
(244)
Net assets
320,097
286,502
Capital and reserves
Called up share capital
10
10
Profit and loss account
320,087
286,492
Shareholders' funds
320,097
286,502
For the year ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board of Directors and authorised for issue on 30 December 2025 and were signed on its behalf by
Tahira Ahmed Director Company Registration No. 6857583
- 4 -
MMO Pharma Ltd Notes to the Accounts for the year ended 31 March 2025
1
Statutory information
MMO Pharma Ltd is a private company, limited by shares, registered in England and Wales, registration number 6857583. The registered office is 4 Rectory Lane, Glinton, Peterborough, PE6 7LR.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Motor vehicles
25% RB
Fixtures & fittings
15% RB
Intangible fixed assets
Intangible fixed assets (including purchased goodwill and patents) are included at cost less accumulated amortisation.
Inventories
Inventories have been valued at the lower of cost and estimated selling price less costs to complete and sell. In respect of work in progress and finished goods, cost includes a relevant proportion of overheads according to the stage of manufacturing/completion.
Deferred taxation
Deferred tax arises as a result of including items of income and expenditure in taxation computations in periods different from those in which they are included in the company's accounts. Deferred tax is provided in full on timing differences which result in an obligation to pay more (or less) tax at a future date, at the average tax rates that are expected to apply when the timing differences reverse, based on current tax rates and laws. Deferred tax assets and liabilities are not discounted.
Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. Turnover from the sale of goods is recognised when goods have been delivered to customers such that risks and rewards of ownership have transferred to them. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
- 5 -
MMO Pharma Ltd Notes to the Accounts for the year ended 31 March 2025
4
Intangible fixed assets
Goodwill
Other
Total
£
£
£
Cost
At 1 April 2024
36,000
2,765
38,765
At 31 March 2025
36,000
2,765
38,765
Amortisation
At 1 April 2024
36,000
2,765
38,765
At 31 March 2025
36,000
2,765
38,765
Net book value
At 31 March 2025
-
-
-
5
Tangible fixed assets
Land & buildings
Motor vehicles
Fixtures & fittings
Total
£
£
£
£
Cost or valuation
At cost
At cost
At cost
At 1 April 2024
92,574
7,010
1,071
100,655
At 31 March 2025
92,574
7,010
1,071
100,655
Depreciation
At 1 April 2024
-
6,132
666
6,798
Charge for the year
-
220
61
281
At 31 March 2025
-
6,352
727
7,079
Net book value
At 31 March 2025
92,574
658
344
93,576
At 31 March 2024
92,574
878
405
93,857
6
Debtors
2025
2024
£
£
Amounts falling due within one year
VAT
7,695
7,479
Accrued income and prepayments
162,155
154,804
Other debtors
208,927
183,451
378,777
345,734
7
Creditors: amounts falling due within one year
2025
2024
£
£
Trade creditors
89,106
84,853
Taxes and social security
19,098
14,180
Loans from directors
36,763
36,764
144,967
135,797
- 6 -
MMO Pharma Ltd Notes to the Accounts for the year ended 31 March 2025
8
Creditors: amounts falling due after more than one year
2025
2024
£
£
Bank loans
59,016
59,016
Other creditors
232
246
59,248
59,262
9
Average number of employees
During the year the average number of employees was 7 (2024: 6).
- 7 -